The impact of network positions in scientific collaboration on pharmaceutical firms' technological innovation performance
Moderating roles of scientific collaboration strength and patent stock
Bibliographic Data
| ID | 22076352 |
|---|---|
| Authors | Xing-Xiu Wang (0000-0002-4461-3541, Health Commission of Jilin Province, corresponding author), Hui-Ying Jiao (Changchun University) |
| Year | 2022 |
| Volume | 10 |
| Pages | 980845-980845 |
| Publication date | 2022-08-10 |
| Open Access | Yes |
| Type | ARTICLE |
| Venue | Frontiers in Public Health (JOURNAL) |
| Journal identifiers | ISSN: 2296-2565 • E-ISSN: 2296-2565 |
| Publisher | Frontiers Media SA (PUBLISHER • CH) |
| DOI | 10.3389/fpubh.2022.980845 |
| PMID | 36033805 |
| OpenAlex | W4292466720 |
| Language | EN |
| Citations received | 2 |
| References cited | 39 |
Scientific knowledge is an underlying basis for technological innovation in the pharmaceutical industry. Collaboration is the main way to participate in the creation of scientific knowledge for pharmaceutical firms. Will network positions in scientific collaboration affect their technological innovation performance? Moreover, what factors moderate the firms' scientific collaboration network positions and technological innovation link? Using a dataset based on 194 Chinese publicly traded pharmaceutical companies, this paper constructs the dynamic scientific collaboration networks among 1,826 organizations by analyzing 4,092 papers included in CNKI and Web of Science databases. Then we probe the impact and boundaries of positions in the scientific collaboration network of pharmaceutical firms on their technological innovation performance through the negative binomial modeling approach. Our study confirms that degree centrality has an inverted U-shaped impact on pharmaceutical firms' technological innovation performance, while structural holes benefit it. Moreover, this article identifies that the strength of scientific collaboration positively moderates the U-shaped relationship between degree centrality and technological innovation of pharmaceutical firms, the matching of high patent stock and high structural holes can promote their technological innovation performance. The results deepen the present understanding of scientific collaboration in the pharmaceutical industry and offer new insights into the formulation of pharmaceutical firms' scientific collaboration strategies
Business · Centrality · Industrial organization · Knowledge management · Pharmaceutical industry · Technological change · Biotechnology and Related Fields · Computer Science · Innovation and Knowledge Management · Pharmaceutical Economics and Policy · Biotechnology · Marketing
Interfirm Collaboration Networks
Links and Impacts
Investigating the factors that diminish the barriers to university–industry collaboration
Team Assembly Mechanisms Determine Collaboration Network Structure and Team Performance
Geographically Localized Knowledge
Exploration and exploitation alliances in biotechnology
Core capabilities and core rigidities
Specification Tests in Econometrics
Structural Holes and Good Ideas
Power and Centrality
| Citations per year | 0.67 |
|---|---|
| Citation span | 2023 - 2023 (1) |
| Highly cited | No |